Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

OBJECTIVE Systemic juvenile idiopathic arthritis (JIA) is frequently associated with the development of macrophage activation syndrome. This study was undertaken to better understand the relationship between systemic JIA and macrophage activation syndrome. METHODS Gene expression profiles were examined in 17 patients with untreated new-onset systemic JIA, 5 of whom showed evidence of subclinical macrophage activation syndrome (of whom 2 eventually developed overt macrophage activation syndrome). Peripheral blood mononuclear cells (PBMCs) were separated on Ficoll gradients, and purified RNA was analyzed using Affymetrix GeneChip expression arrays. A fraction of the PBMCs were used for flow cytometry to define the cellular composition of the samples. RESULTS Two hundred twenty-five differentially expressed genes (P < 0.05) that distinguished patients with systemic JIA from healthy controls (n = 30) were identified. Clustering analysis indicated that expression patterns correlated with serum ferritin levels. Three main clusters distinguished systemic JIA patients with highly elevated ferritin levels (including those with subclinical macrophage activation syndrome) from those with normal or only moderately elevated ferritin levels. The first cluster comprised genes involved in the synthesis of hemoglobins and structural proteins of erythrocytes. This transcriptional profile was consistent with immature nucleated red blood cells, likely reflective of high red blood cell turnover. Also included were transcripts indicating immature granulocytes. The second cluster was enriched for genes involved in cell cycle regulation. The third cluster was enriched for genes involved in innate immune responses, including those involved in the negative regulation of Toll-like receptor/interleukin-1 receptor-triggered inflammatory cascades and markers of the alternative pathway of macrophage differentiation. Additional differentially expressed genes of interest were those involved in the cytolytic pathway, including SH2D1A and Rab27a. CONCLUSION These data indicate that gene expression profiling can be a useful tool for identifying early macrophage activation syndrome in patients with systemic JIA.

[1]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[2]  E. Giannini,et al.  Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome , 2004, Arthritis research & therapy.

[3]  A. Martini,et al.  Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis? , 2005, Arthritis and rheumatism.

[4]  M. Suarez‐Almazor,et al.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.

[5]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[6]  O. Levy.  Antimicrobial proteins and peptides: anti‐infective molecules of mammalian leukocytes , 2004, Journal of leukocyte biology.

[7]  A. Ramanan,et al.  The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[8]  P. Woo,et al.  Phase II trial of anti-IL-6 receptor antibody (MRA) for children with systemic-onset juvenile idiopathic arthritis , 2003 .

[9]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[10]  C. Griscelli,et al.  Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. , 1985, The Journal of pediatrics.

[11]  S. Sawhney,et al.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders , 2001, Archives of disease in childhood.

[12]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[13]  M. Lovett,et al.  Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.

[14]  J. Miyazaki,et al.  Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice , 2003, The Journal of experimental medicine.

[15]  R. Schneider,et al.  6 Systemic onset juvenile rheumatoid arthritis , 1998 .

[16]  B. Athreya.  Is macrophage activation syndrome a new entity? , 2002, Clinical and experimental rheumatology.

[17]  A. Grom.  Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? , 2004, Arthritis and rheumatism.

[18]  A. Fischer,et al.  Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3) , 2003, Cell.

[19]  A. Solinger,et al.  Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. , 2005, Arthritis and rheumatism.

[20]  J. Verbsky,et al.  Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. , 2004, The Journal of rheumatology.

[21]  H. Tian,et al.  Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84* , 2006, Journal of Biological Chemistry.

[22]  Donald Metcalf,et al.  SOCS3 negatively regulates IL-6 signaling in vivo , 2003, Nature Immunology.

[23]  W. Alexander,et al.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. , 2006, The Journal of clinical investigation.

[24]  T. Tedder,et al.  Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. , 2001, Genomics.

[25]  Kaiyu Jiang,et al.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis , 2003, Arthritis research & therapy.

[26]  J. Schneider-Mergener,et al.  Synthetic Endotoxin-Binding Peptides Block Endotoxin- Triggered TNF-α Production by Macrophages In Vitro and In Vivo and Prevent Endotoxin-Mediated Toxic Shock , 2000, The Journal of Immunology.

[27]  S. Holland,et al.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. , 2006, The New England journal of medicine.

[28]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[29]  E. Beale,et al.  FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells , 2005, BMC Genomics.

[30]  J. Larghero,et al.  Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34+ cell quantification , 2006, Transfusion.

[31]  R. Nau,et al.  Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists , 2007, Neuroscience Letters.

[32]  A. Filipovich.  Hemophagocytic lymphohistiocytosis and related disorders , 2006, Current opinion in allergy and clinical immunology.

[33]  V. Pascual,et al.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.

[34]  M. Kurrer,et al.  Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis , 2006, European journal of haematology.

[35]  S. Vogel,et al.  Up‐regulation of human monocyte CD163 upon activation of cell‐surface Toll‐like receptors , 2007, Journal of leukocyte biology.

[36]  A. Fischer,et al.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome , 2000, Nature Genetics.

[37]  Ping Wang,et al.  Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: Down-regulation of proinflammatory cytokines , 2002, Critical care medicine.

[38]  Y. Satta,et al.  Chemically synthesized pathogen‐associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll‐like receptors, NOD1 and NOD2 in human oral epithelial cells , 2005, Cellular microbiology.

[39]  Guang-Xian Zhang,et al.  Dendritic Cells Transduced with SOCS-3 Exhibit a Tolerogenic/DC2 Phenotype That Directs Type 2 Th Cell Differentiation In Vitro and In Vivo1 , 2006, The Journal of Immunology.

[40]  S. Portal-Nuñez,et al.  The central role of adrenomedullin in host defense , 2006, Journal of leukocyte biology.

[41]  K. Ogawa,et al.  Activin A Functions as a Th2 Cytokine in the Promotion of the Alternative Activation of Macrophages1 , 2006, The Journal of Immunology.

[42]  R. Cron,et al.  Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. , 2007, The Journal of rheumatology.

[43]  J. Johnston,et al.  Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. , 1999, Journal of immunology.

[44]  R. Schneider,et al.  Radiologic features of systemic onset juvenile rheumatoid arthritis. , 1995, The Journal of rheumatology.

[45]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[46]  A. Ramanan,et al.  Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? , 2005, Rheumatology.

[47]  H. Hennies,et al.  Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A , 2006, Human mutation.

[48]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Gemsa,et al.  Shift toward an alternatively activated macrophage response in lungs of NO2-exposed rats. , 2003, American journal of respiratory cell and molecular biology.

[50]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[51]  M. Kurrer,et al.  Soluble hemoglobin–haptoglobin scavenger receptor CD163 as a lineage‐specific marker in the reactive hemophagocytic syndrome , 2005, European journal of haematology.

[52]  H. Hennies,et al.  Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. , 2005, Human molecular genetics.